
William L. Miller
Examiner (ID: 12563, Phone: (571)272-7068 , Office: P/3677 )
| Most Active Art Unit | 3677 |
| Art Unit(s) | 3628, 3633, 3677, 3509 |
| Total Applications | 3224 |
| Issued Applications | 2464 |
| Pending Applications | 166 |
| Abandoned Applications | 639 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18108092
[patent_doc_number] => 20230000972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => ATTENUATED AVIAN REOVIRUS STRAINS 94826 C140 AND 97139 C140
[patent_app_type] => utility
[patent_app_number] => 17/779811
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7405
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779811
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779811 | ATTENUATED AVIAN REOVIRUS STRAINS 94826 C140 AND 97139 C140 | Nov 30, 2020 | Pending |
Array
(
[id] => 18101246
[patent_doc_number] => 11541115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Triple vaccine against
[patent_app_type] => utility
[patent_app_number] => 17/104457
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16294
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104457
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104457 | Triple vaccine against | Nov 24, 2020 | Issued |
Array
(
[id] => 18177758
[patent_doc_number] => 20230038487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => MODIFIED VIRAL THERAPEUTICS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/779484
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779484 | MODIFIED VIRAL THERAPEUTICS AND USES THEREOF | Nov 18, 2020 | Pending |
Array
(
[id] => 16749953
[patent_doc_number] => 20210101962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => Mosaic Chimeric Viral Vaccine Particle
[patent_app_type] => utility
[patent_app_number] => 16/950297
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950297
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950297 | Mosaic chimeric viral vaccine particle | Nov 16, 2020 | Issued |
Array
(
[id] => 17168872
[patent_doc_number] => 20210322542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/098449
[patent_app_country] => US
[patent_app_date] => 2020-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17098449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/098449 | VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE | Nov 14, 2020 | Abandoned |
Array
(
[id] => 18075934
[patent_doc_number] => 20220401546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => HIV Immunogens, Vaccines, and Methods Related Thereto
[patent_app_type] => utility
[patent_app_number] => 17/776896
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776896 | HIV Immunogens, Vaccines, and Methods Related Thereto | Nov 12, 2020 | Abandoned |
Array
(
[id] => 18065721
[patent_doc_number] => 20220396808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => VIRAL CAPSID POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/774315
[patent_app_country] => US
[patent_app_date] => 2020-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774315
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774315 | VIRAL CAPSID POLYPEPTIDES | Nov 5, 2020 | Pending |
Array
(
[id] => 20386778
[patent_doc_number] => 12486497
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => F-genotype mumps virus attenuated strain and construction method therefor and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/755663
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 2022
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755663
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755663 | F-genotype mumps virus attenuated strain and construction method therefor and application thereof | Nov 2, 2020 | Issued |
Array
(
[id] => 18163386
[patent_doc_number] => 20230029979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => BROADLY PROTECTIVE BOVINE PARAINFLUENZA 3 VIRUS AND BOVINE VIRAL DIARRHEA VIRUS VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/755359
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7955
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755359
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755359 | BROADLY PROTECTIVE BOVINE PARAINFLUENZA 3 VIRUS AND BOVINE VIRAL DIARRHEA VIRUS VACCINE | Oct 29, 2020 | Pending |
Array
(
[id] => 18108089
[patent_doc_number] => 20230000969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => IMPROVED VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/771736
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17771736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/771736 | IMPROVED VACCINES FOR RECURRENT RESPIRATORY PAPILLOMATOSIS AND METHODS FOR USING THE SAME | Oct 25, 2020 | Pending |
Array
(
[id] => 19032588
[patent_doc_number] => 20240082403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Chimeric Antigen Receptors against Human Cytomegalovirus
[patent_app_type] => utility
[patent_app_number] => 17/766989
[patent_app_country] => US
[patent_app_date] => 2020-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766989 | Chimeric Antigen Receptors against Human Cytomegalovirus | Oct 11, 2020 | Pending |
Array
(
[id] => 16762600
[patent_doc_number] => 20210108181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => RIFT VALLEY FEVER VACCINE
[patent_app_type] => utility
[patent_app_number] => 17/067144
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17067144
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/067144 | Rift valley fever vaccine | Oct 8, 2020 | Issued |
Array
(
[id] => 17532423
[patent_doc_number] => 20220111032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => IMMUNOGENIC COMPOSITION FOR PORCINE EPIDEMIC DIARRHEA VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/065535
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065535
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065535 | IMMUNOGENIC COMPOSITION FOR PORCINE EPIDEMIC DIARRHEA VIRUS | Oct 7, 2020 | Abandoned |
Array
(
[id] => 16569216
[patent_doc_number] => 20210008222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => PLANT VIRUS PARTICLES FOR DELIVERY OF ANTIMITOTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/030793
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/030793 | Plant virus particles for delivery of antimitotic agents | Sep 23, 2020 | Issued |
Array
(
[id] => 19338570
[patent_doc_number] => 12048741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Recombinant host cell with heterologous nucleic acids encoding SHREK proteins
[patent_app_type] => utility
[patent_app_number] => 17/031082
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 18
[patent_no_of_words] => 11072
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031082
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/031082 | Recombinant host cell with heterologous nucleic acids encoding SHREK proteins | Sep 23, 2020 | Issued |
Array
(
[id] => 17865452
[patent_doc_number] => 20220288187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION
[patent_app_type] => utility
[patent_app_number] => 17/763184
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5271
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763184 | BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION | Sep 22, 2020 | Abandoned |
Array
(
[id] => 19225483
[patent_doc_number] => 12005113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom
[patent_app_type] => utility
[patent_app_number] => 17/021261
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 198
[patent_figures_cnt] => 236
[patent_no_of_words] => 40575
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021261 | Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom | Sep 14, 2020 | Issued |
Array
(
[id] => 17921628
[patent_doc_number] => 11464849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/017342
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 50
[patent_no_of_words] => 40258
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/017342 | Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof | Sep 9, 2020 | Issued |
Array
(
[id] => 16989387
[patent_doc_number] => 20210227807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/992760
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992760
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992760 | METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM | Aug 12, 2020 | Abandoned |
Array
(
[id] => 16915858
[patent_doc_number] => 20210188950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Antibodies Against F Glycoprotein of Hendra and Nipah Viruses
[patent_app_type] => utility
[patent_app_number] => 16/988835
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988835
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/988835 | Antibodies against F glycoprotein of Hendra and Nipah viruses | Aug 9, 2020 | Issued |